CIK 0001653087 · Accelerated filer<br>Smaller reporting company
Alector, Inc.
Sign in to watch- Ticker
- ALEC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 822933343
- Phone
- 415-231-5660
- Business address
- 131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Alector LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $296,087
- in 3 filings
Net −$296,087. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 76 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-05-07 | Paul Robert Chief Medical Officer | Grant or award | +60,000 | 273,719 | ||
| 2021-05-07 | King Robert Chief Development Officer | Grant or award | +45,000 | 522,317 | ||
| 2021-05-07 | SULIMAN SHEHNAAZ President and COO | Grant or award | +100,000 | 100,000 | ||
| 2021-05-07 | Rosenthal Arnon Chief Executive Officer | Grant or award | +150,000 | 1,455,226 | ||
| 2021-04-07 | Paul Robert Chief Medical Officer | Option exercise | +17,092 | $8.16 | $139K | 230,811 |
| 2021-04-07 | Paul Robert Chief Medical Officer | Option exercise | +2,083 | $10.14 | $21K | 232,894 |
| 2021-04-07 | Paul Robert Chief Medical Officer | Option exercise | +3,125 | $17.15 | $54K | 236,019 |
| 2021-04-07 | Paul Robert Chief Medical Officer | Sale | −22,255 | $19.19 | $427K | 213,764 |
| 2021-04-07 | Paul Robert Chief Medical Officer | Sale | −45 | $19.83 | $892 | 213,719 |
| 2021-04-07 | Paul Robert Chief Medical Officer | Option exercise · Employee Stock Option (right to buy) | −17,092 | 139,466 | ||
| 2021-04-07 | Paul Robert Chief Medical Officer | Option exercise · Employee Stock Option (right to buy) | −2,083 | 56,251 | ||
| 2021-04-07 | Paul Robert Chief Medical Officer | Option exercise · Employee Stock Option (right to buy) | −3,125 | 146,875 | ||
| 2021-03-23 | Paul Robert Chief Medical Officer | Option exercise | +13,800 | $8.16 | $113K | 227,519 |
| 2021-03-23 | Paul Robert Chief Medical Officer | Sale | −13,800 | $22.21 | $306K | 213,719 |
| 2021-03-22 | Paul Robert Chief Medical Officer | Option exercise | +30,000 | $8.16 | $245K | 243,719 |
| 2021-03-22 | Paul Robert Chief Medical Officer | Sale | −24,490 | $22.85 | $560K | 219,229 |
| 2021-03-22 | Paul Robert Chief Medical Officer | Sale | −5,510 | $23.55 | $130K | 213,719 |
| 2021-03-22 | Paul Robert Chief Medical Officer | Option exercise · Employee Stock Option (right to buy) | −30,000 | 170,358 | ||
| 2021-03-22 | Paul Robert Chief Medical Officer | Option exercise · Employee Stock Option (right to buy) | −13,800 | 156,558 | ||
| 2021-03-09 | Paul Robert Chief Medical Officer | Option exercise | +17,092 | $8.16 | $139K | 230,811 |
Page 21 of 23 · 454 trades